Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2013

01-01-2013 | Review

Clinical Utility of 13C-Liver-Function Breath Tests for Assessment of Hepatic Function

Authors: P. Afolabi, M. Wright, S. A. Wootton, A. A. Jackson

Published in: Digestive Diseases and Sciences | Issue 1/2013

Login to get access

Abstract

13C-Liver-function breath tests have been used in clinical diagnostics and, to a limited extent, to investigate hepatic function. From a practical perspective, tests such as the 13C-aminopyrine and 13C-methacetin breath tests are simple to administer, safe, and relatively inexpensive to perform. Surprisingly, they have not entered the mainstream of clinical practice, because they are perceived to lack the specificity and adequate precision needed to give accurate results in real time. The dynamic nature of 13C-liver-function breath tests, their possible versatility in terms of assessing a range of different liver functions, and the ease with which they can be repeated to follow relative changes in liver function with time, all imply the potential for wider clinical application. Therefore, there is a need for these tests to be critically evaluated and their potential clinical application be tested systematically against defined objectives. We describe refinements in the methodology of the tests and propose several situations in which currently reliable methods for assessment of liver function do not exist and where 13C-liver-function breath tests might be of use. We propose that use has been constrained by practical methodological considerations which could be addressed to offer tests better suited to routine application in the out-patient or community setting.
Literature
1.
go back to reference Banasch M, Goetze O, Hollborn I, et al. 13C-methionine breath test detects distinct hepatic mitochondrial dysfunction in HIV-infected patients with normal serum lactate. J Acquir Immune Defic Syndr. 2005;40:149–154.PubMedCrossRef Banasch M, Goetze O, Hollborn I, et al. 13C-methionine breath test detects distinct hepatic mitochondrial dysfunction in HIV-infected patients with normal serum lactate. J Acquir Immune Defic Syndr. 2005;40:149–154.PubMedCrossRef
2.
go back to reference Giannini E, Fasoli A, Chiarbonello B, et al. 13C-aminopyrine breath test to evaluate severity of disease in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther. 2002;16:717–725.PubMedCrossRef Giannini E, Fasoli A, Chiarbonello B, et al. 13C-aminopyrine breath test to evaluate severity of disease in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther. 2002;16:717–725.PubMedCrossRef
3.
go back to reference Lalazar G, Adar T, Ilan Y. Point-of-care continuous 13C-methacetin breath test improves decision making in acute liver disease: results of a pilot clinical trial. World J Gastroenterol. 2009;15:966–972.PubMedCrossRef Lalazar G, Adar T, Ilan Y. Point-of-care continuous 13C-methacetin breath test improves decision making in acute liver disease: results of a pilot clinical trial. World J Gastroenterol. 2009;15:966–972.PubMedCrossRef
4.
go back to reference Koeda N, Iwai M, Kato A, Suzuki K. Validity of 13C-phenylalanine breath test to evaluate functional capacity of hepatocyte in patients with liver cirrhosis and acute hepatitis. Aliment Pharmacol Ther. 2005;21:851–859.PubMedCrossRef Koeda N, Iwai M, Kato A, Suzuki K. Validity of 13C-phenylalanine breath test to evaluate functional capacity of hepatocyte in patients with liver cirrhosis and acute hepatitis. Aliment Pharmacol Ther. 2005;21:851–859.PubMedCrossRef
5.
go back to reference Gallardo-Wong I, Moran S, Rodriguez-Leal G, et al. Prognostic value of 13C-phenylalanine breath test on predicting survival in patients with chronic liver failure. World J Gastroenterol. 2007;13:4579–4585.PubMed Gallardo-Wong I, Moran S, Rodriguez-Leal G, et al. Prognostic value of 13C-phenylalanine breath test on predicting survival in patients with chronic liver failure. World J Gastroenterol. 2007;13:4579–4585.PubMed
6.
go back to reference Schmidt LE, Olsen AK, Stentoft K, Rasmussen A, Kirkegaard P, Dalhoff K. Early postoperative erythromycin breath test correlates with hepatic cytochrome P4503A activity in liver transplant recipients. Clin Pharmacol Ther. 2001;70:446–454.PubMed Schmidt LE, Olsen AK, Stentoft K, Rasmussen A, Kirkegaard P, Dalhoff K. Early postoperative erythromycin breath test correlates with hepatic cytochrome P4503A activity in liver transplant recipients. Clin Pharmacol Ther. 2001;70:446–454.PubMed
7.
go back to reference Petrolati A, Festi D, De Berardinis G, et al. 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Aliment Pharmacol Ther. 2003;18:785–790.PubMedCrossRef Petrolati A, Festi D, De Berardinis G, et al. 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Aliment Pharmacol Ther. 2003;18:785–790.PubMedCrossRef
8.
go back to reference Di Campli C, Angelini G, Armuzzi A, et al. Quantitative evaluation of liver function by the methionine and aminopyrine breath tests in the early stages of liver transplantation. Eur J Gastroenterol Hepatol. 2003;15:727–732.PubMedCrossRef Di Campli C, Angelini G, Armuzzi A, et al. Quantitative evaluation of liver function by the methionine and aminopyrine breath tests in the early stages of liver transplantation. Eur J Gastroenterol Hepatol. 2003;15:727–732.PubMedCrossRef
9.
go back to reference Armuzzi A, Candelli M, Zocco MA, et al. Review article: breath testing for human liver function assessment. Aliment Pharmacol Ther. 2002;16:1977–1996.PubMedCrossRef Armuzzi A, Candelli M, Zocco MA, et al. Review article: breath testing for human liver function assessment. Aliment Pharmacol Ther. 2002;16:1977–1996.PubMedCrossRef
10.
go back to reference Perri F, Marras RM, Ricciardi R, Quitadamo M, Andriulli A. 13C-breath tests in hepatology (cytosolic liver function). Eur Rev Med Pharmacol Sci. 2004;8:47–49.PubMed Perri F, Marras RM, Ricciardi R, Quitadamo M, Andriulli A. 13C-breath tests in hepatology (cytosolic liver function). Eur Rev Med Pharmacol Sci. 2004;8:47–49.PubMed
11.
go back to reference Burke PA, Stack JA, Wagner D, Lewis DW, Jenkins RL, Forse RA. L-[1-13C] Phenylalanine oxidation as a measure of hepatocyte functional capacity in end-stage liver disease. Am J Surg. 1997;173:270–273.PubMedCrossRef Burke PA, Stack JA, Wagner D, Lewis DW, Jenkins RL, Forse RA. L-[1-13C] Phenylalanine oxidation as a measure of hepatocyte functional capacity in end-stage liver disease. Am J Surg. 1997;173:270–273.PubMedCrossRef
12.
go back to reference Ishii Y, Suzuki S, Kohno T, et al. L-[1-13C] phenylalanine breath test reflects histological changes in the liver. J Surg Res. 2003;114:120–125.PubMedCrossRef Ishii Y, Suzuki S, Kohno T, et al. L-[1-13C] phenylalanine breath test reflects histological changes in the liver. J Surg Res. 2003;114:120–125.PubMedCrossRef
13.
go back to reference Cuatrecasas P, Segal S. Mammalian galactokinase. Developmental and adaptive characteristics in the rat liver. J Biol Chem. 1965;240:2382–2388.PubMed Cuatrecasas P, Segal S. Mammalian galactokinase. Developmental and adaptive characteristics in the rat liver. J Biol Chem. 1965;240:2382–2388.PubMed
14.
go back to reference Holtmeier J, Leuschner M, Schneider A, Leuschner U, Caspary WF, Braden B. 13C-methacetin and 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis. Scand J Gastroenterol. 2006;41:1336–1341.PubMedCrossRef Holtmeier J, Leuschner M, Schneider A, Leuschner U, Caspary WF, Braden B. 13C-methacetin and 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis. Scand J Gastroenterol. 2006;41:1336–1341.PubMedCrossRef
15.
go back to reference Giannini EG, Fasoli A, Borro P, et al. 13C-galactose breath test and 13C-aminopyrine breath test for the study of liver function in chronic liver disease. Clin Gastroenterol Hepatol. 2005;3:279–285.PubMedCrossRef Giannini EG, Fasoli A, Borro P, et al. 13C-galactose breath test and 13C-aminopyrine breath test for the study of liver function in chronic liver disease. Clin Gastroenterol Hepatol. 2005;3:279–285.PubMedCrossRef
16.
go back to reference Stibbe KJ, Verveer C, Francke J, et al. Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients. Scand J Gastroenterol. 2011;46:962–972.PubMedCrossRef Stibbe KJ, Verveer C, Francke J, et al. Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients. Scand J Gastroenterol. 2011;46:962–972.PubMedCrossRef
17.
go back to reference Candelli M, Cazzato IA, Zocco MA, et al. 13C-breath tests in the study of mitochondrial liver function. Eur Rev Med Pharmacol Sci. 2004;8:23–31.PubMed Candelli M, Cazzato IA, Zocco MA, et al. 13C-breath tests in the study of mitochondrial liver function. Eur Rev Med Pharmacol Sci. 2004;8:23–31.PubMed
18.
go back to reference Grattagliano I, Lauterburg BH, Palasciano G, Portincasa P. 13C-breath tests for clinical investigation of liver mitochondrial function. Eur J Clin Invest. 2010;40:843–850.PubMedCrossRef Grattagliano I, Lauterburg BH, Palasciano G, Portincasa P. 13C-breath tests for clinical investigation of liver mitochondrial function. Eur J Clin Invest. 2010;40:843–850.PubMedCrossRef
19.
go back to reference Michaletz PA, Cap L, Alpert E, Lauterburg BH. Assessment of mitochondrial function in vivo with a breath test utilizing alpha-ketoisocaproic acid. Hepatology. 1989;10:829–832.PubMedCrossRef Michaletz PA, Cap L, Alpert E, Lauterburg BH. Assessment of mitochondrial function in vivo with a breath test utilizing alpha-ketoisocaproic acid. Hepatology. 1989;10:829–832.PubMedCrossRef
20.
go back to reference Honkoop P, de Man RA, Scholte HR, et al. Effect of lamivudine on morphology and function of mitochondria in patients with chronic hepatitis B. Hepatology. 1997;26:211–215.PubMedCrossRef Honkoop P, de Man RA, Scholte HR, et al. Effect of lamivudine on morphology and function of mitochondria in patients with chronic hepatitis B. Hepatology. 1997;26:211–215.PubMedCrossRef
21.
go back to reference Lauterburg BH, Liang D, Schwarzenbach FA, Breen KJ. Mitochondrial dysfunction in alcoholic patients as assessed by breath analysis. Hepatology. 1993;17:418–422.PubMedCrossRef Lauterburg BH, Liang D, Schwarzenbach FA, Breen KJ. Mitochondrial dysfunction in alcoholic patients as assessed by breath analysis. Hepatology. 1993;17:418–422.PubMedCrossRef
22.
go back to reference Witschi A, Mossi S, Meyer B, Junker E, Lauterburg BH. Mitochondrial function reflected by the decarboxylation of [13C]ketoisocaproate is impaired in alcoholics. Alcohol Clin Exp Res. 1994;18:951–955.PubMedCrossRef Witschi A, Mossi S, Meyer B, Junker E, Lauterburg BH. Mitochondrial function reflected by the decarboxylation of [13C]ketoisocaproate is impaired in alcoholics. Alcohol Clin Exp Res. 1994;18:951–955.PubMedCrossRef
23.
go back to reference Portincasa P, Grattagliano I, Lauterburg BH, Palmieri VO, Palasciano G, Stellaard F. Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis. Clin Sci (Lond). 2006;111:135–143.CrossRef Portincasa P, Grattagliano I, Lauterburg BH, Palmieri VO, Palasciano G, Stellaard F. Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis. Clin Sci (Lond). 2006;111:135–143.CrossRef
24.
go back to reference Palmieri VO, Grattagliano I, Minerva F, Pollice S, Palasciano G, Portincasa P. Liver function as assessed by breath tests in patients with hepatocellular carcinoma. J Surg Res. 2009;157:199–207.PubMedCrossRef Palmieri VO, Grattagliano I, Minerva F, Pollice S, Palasciano G, Portincasa P. Liver function as assessed by breath tests in patients with hepatocellular carcinoma. J Surg Res. 2009;157:199–207.PubMedCrossRef
25.
go back to reference Mato JM, Alvarez L, Ortiz P, Pajares MA. S-adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol Ther. 1997;73:265–280.PubMedCrossRef Mato JM, Alvarez L, Ortiz P, Pajares MA. S-adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol Ther. 1997;73:265–280.PubMedCrossRef
26.
go back to reference Banasch M, Frank J, Serova K, et al. Impact of antiretroviral treatment on 13C-methionine metabolism as a marker of hepatic mitochondrial function: a longitudinal study. HIV Med. 2011;12:40–45.PubMedCrossRef Banasch M, Frank J, Serova K, et al. Impact of antiretroviral treatment on 13C-methionine metabolism as a marker of hepatic mitochondrial function: a longitudinal study. HIV Med. 2011;12:40–45.PubMedCrossRef
27.
go back to reference Banasch M, Ellrichmann M, Tannapfel A, Schmidt WE, Goetze O. The non-invasive 13C-methionine breath test detects hepatic mitochondrial dysfunction as a marker of disease activity in non-alcoholic steatohepatitis. Eur J Med Res. 2011;16:258.PubMedCrossRef Banasch M, Ellrichmann M, Tannapfel A, Schmidt WE, Goetze O. The non-invasive 13C-methionine breath test detects hepatic mitochondrial dysfunction as a marker of disease activity in non-alcoholic steatohepatitis. Eur J Med Res. 2011;16:258.PubMedCrossRef
28.
go back to reference Schneider AR, Kraut C, Lindenthal B, Braden B, Caspary WF, Stein J. Total body metabolism of 13C-octanoic acid is preserved in patients with non-alcoholic steatohepatitis, but differs between women and men. Eur J Gastroenterol Hepatol. 2005;17:1181–1184.PubMedCrossRef Schneider AR, Kraut C, Lindenthal B, Braden B, Caspary WF, Stein J. Total body metabolism of 13C-octanoic acid is preserved in patients with non-alcoholic steatohepatitis, but differs between women and men. Eur J Gastroenterol Hepatol. 2005;17:1181–1184.PubMedCrossRef
29.
go back to reference Mawatari H, Inamori M, Fujita K, et al. The continuous real-time 13C-octanoate breath test for patients with nonalcoholic steatohepatitis using the BreathID system. Hepatogastroenterology. 2009;56:1436–1438.PubMed Mawatari H, Inamori M, Fujita K, et al. The continuous real-time 13C-octanoate breath test for patients with nonalcoholic steatohepatitis using the BreathID system. Hepatogastroenterology. 2009;56:1436–1438.PubMed
30.
go back to reference Perri F, Pastore M, Annese V, Andriulli A. The aminopyrine breath test. Ital J Gastroenterol. 1994;26:306–317.PubMed Perri F, Pastore M, Annese V, Andriulli A. The aminopyrine breath test. Ital J Gastroenterol. 1994;26:306–317.PubMed
31.
go back to reference Nista EC, Fini L, Armuzzi A, et al. 13C-breath tests in the study of microsomal liver function. Eur Rev Med Pharmacol Sci. 2004;8:33–46.PubMed Nista EC, Fini L, Armuzzi A, et al. 13C-breath tests in the study of microsomal liver function. Eur Rev Med Pharmacol Sci. 2004;8:33–46.PubMed
32.
go back to reference Bircher J, Kupfer A, Gikalov I, Preisig R. Aminopyrine demethylation measured by breath analysis in cirrhosis. Clin Pharmacol Ther. 1976;20:484–492.PubMed Bircher J, Kupfer A, Gikalov I, Preisig R. Aminopyrine demethylation measured by breath analysis in cirrhosis. Clin Pharmacol Ther. 1976;20:484–492.PubMed
33.
go back to reference Schneider JF, Baker AL, Haines NW, Hatfield G, Boyer JL. Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease. Gastroenterology. 1980;79:1145–1150.PubMed Schneider JF, Baker AL, Haines NW, Hatfield G, Boyer JL. Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease. Gastroenterology. 1980;79:1145–1150.PubMed
34.
go back to reference Monroe PS, Baker AL, Schneider JF, Krager PS, Klein PD, Schoeller D. The aminopyrine breath test and serum bile acids reflect histologic severity in chronic hepatitis. Hepatology. 1982;2:317–322.PubMedCrossRef Monroe PS, Baker AL, Schneider JF, Krager PS, Klein PD, Schoeller D. The aminopyrine breath test and serum bile acids reflect histologic severity in chronic hepatitis. Hepatology. 1982;2:317–322.PubMedCrossRef
35.
go back to reference Vesell ES. Non invasive assessment in vivo of hepatic drug metabolism in health and disease. Ann NY acad sci. 1984;428:293–307.PubMedCrossRef Vesell ES. Non invasive assessment in vivo of hepatic drug metabolism in health and disease. Ann NY acad sci. 1984;428:293–307.PubMedCrossRef
36.
go back to reference Ilan Y. Review article: the assessment of liver function using breath tests. Aliment Pharmacol Ther. 2007;26:1293–1302.PubMedCrossRef Ilan Y. Review article: the assessment of liver function using breath tests. Aliment Pharmacol Ther. 2007;26:1293–1302.PubMedCrossRef
37.
go back to reference Lalazar G, Pappo O, Hershcovici T, et al. A continuous 13C methacetin breath test for non-invasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT. J Viral Hepat. 2008;15:716–728.PubMedCrossRef Lalazar G, Pappo O, Hershcovici T, et al. A continuous 13C methacetin breath test for non-invasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT. J Viral Hepat. 2008;15:716–728.PubMedCrossRef
38.
go back to reference Dinesen L, Caspary WF, Chapman RW, Dietrich CF, Sarrazin C, Braden B. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C. Dig Liver Dis. 2008;40:743–748.PubMedCrossRef Dinesen L, Caspary WF, Chapman RW, Dietrich CF, Sarrazin C, Braden B. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C. Dig Liver Dis. 2008;40:743–748.PubMedCrossRef
39.
go back to reference Candelli M, Armuzzi A, Nista EC, Fini L, Gasbarrini G, Gasbarrini A. 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Aliment Pharmacol Ther. 2004;19:243.PubMedCrossRef Candelli M, Armuzzi A, Nista EC, Fini L, Gasbarrini G, Gasbarrini A. 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Aliment Pharmacol Ther. 2004;19:243.PubMedCrossRef
40.
go back to reference Festi D, Capodicasa S, Sandri L, et al. Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child–Pugh score and serum bile acid levels. World J Gastroenterol. 2005;11:142–148.PubMed Festi D, Capodicasa S, Sandri L, et al. Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child–Pugh score and serum bile acid levels. World J Gastroenterol. 2005;11:142–148.PubMed
41.
go back to reference Lijmer JG, Leeflang M, Bossuyt PM. Proposals for a phased evaluation of medical tests. Med Decis Making. 2009;29:E13–E21.PubMedCrossRef Lijmer JG, Leeflang M, Bossuyt PM. Proposals for a phased evaluation of medical tests. Med Decis Making. 2009;29:E13–E21.PubMedCrossRef
42.
go back to reference Menzies D. Evaluating new diagnostic tests in the field—are we doing it right? BMC Proc. 2011;4:13.CrossRef Menzies D. Evaluating new diagnostic tests in the field—are we doing it right? BMC Proc. 2011;4:13.CrossRef
43.
go back to reference Atkins D, Briss PA, Eccles M, et al. Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system. BMC Health Serv Res. 2005;5:25.PubMedCrossRef Atkins D, Briss PA, Eccles M, et al. Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system. BMC Health Serv Res. 2005;5:25.PubMedCrossRef
44.
go back to reference Parra D, Gonzalez A, Garcia-Villarreal L, Martinez JA. Methodological characterization of the 2-keto [1-13C]isocaproate breath test to measure in vivo human mitochondrial function: application in alcoholic liver disease assessment. Alcohol Clin Exp Res. 2003;27:1293–1298.PubMedCrossRef Parra D, Gonzalez A, Garcia-Villarreal L, Martinez JA. Methodological characterization of the 2-keto [1-13C]isocaproate breath test to measure in vivo human mitochondrial function: application in alcoholic liver disease assessment. Alcohol Clin Exp Res. 2003;27:1293–1298.PubMedCrossRef
45.
go back to reference Afolabi P, Wright M, Wootton S, Jackson AA. A comparison of the reproducibility of the parameters of the 13C-aminopyrine breath test for the assessment of hepatic function. Isotopes Environ Health Stud. 2011;47:390–399.PubMedCrossRef Afolabi P, Wright M, Wootton S, Jackson AA. A comparison of the reproducibility of the parameters of the 13C-aminopyrine breath test for the assessment of hepatic function. Isotopes Environ Health Stud. 2011;47:390–399.PubMedCrossRef
46.
go back to reference Amarri S, Weaver LT. 13C-breath tests to measure fat and carbohydrate digestion in clinical practice. Clinical Nutrition. 1995;14:149–154. Amarri S, Weaver LT. 13C-breath tests to measure fat and carbohydrate digestion in clinical practice. Clinical Nutrition. 1995;14:149–154.
47.
go back to reference Shreeve WW, Shoop JD, Ott DG, McInteer BB. Test for alcoholic cirrhosis by conversion of [14C]- or [13C]galactose to expired CO2. Gastroenterology. 1976;71:98–101.PubMed Shreeve WW, Shoop JD, Ott DG, McInteer BB. Test for alcoholic cirrhosis by conversion of [14C]- or [13C]galactose to expired CO2. Gastroenterology. 1976;71:98–101.PubMed
48.
go back to reference Irving CS, Wong WW, Shulman RJ, Smith EO, Klein PD. [13C]-bicarbonate kinetics in humans: intra- vs. interindividual variations. Am J Physiol. 1983;245:R190–R202.PubMed Irving CS, Wong WW, Shulman RJ, Smith EO, Klein PD. [13C]-bicarbonate kinetics in humans: intra- vs. interindividual variations. Am J Physiol. 1983;245:R190–R202.PubMed
49.
go back to reference Henderson G, Secor J, Heitman D, Schenker S. Effects of age and sex on the hepatic monoxygenase system: a correlative approach. Dev Pharmacol Ther. 1986;9:201–216.PubMed Henderson G, Secor J, Heitman D, Schenker S. Effects of age and sex on the hepatic monoxygenase system: a correlative approach. Dev Pharmacol Ther. 1986;9:201–216.PubMed
51.
go back to reference Schneider AR, Teuber G, Paul K, et al. Patient age is a strong independent predictor of 13C-aminopyrine breath test results: a comparative study with histology, duplex-Doppler and a laboratory index in patients with chronic hepatitis C virus infection. Clin Exp Pharmacol Physiol. 2006;33:300–304.PubMedCrossRef Schneider AR, Teuber G, Paul K, et al. Patient age is a strong independent predictor of 13C-aminopyrine breath test results: a comparative study with histology, duplex-Doppler and a laboratory index in patients with chronic hepatitis C virus infection. Clin Exp Pharmacol Physiol. 2006;33:300–304.PubMedCrossRef
52.
go back to reference Slater C, Preston T, Weaver LT. Is there an advantage in normalising the results of the Helicobacter pylori [13C]urea breath test for CO2 production rate in children? Isotopes Environ Health Stud. 2004;40:89–98.PubMedCrossRef Slater C, Preston T, Weaver LT. Is there an advantage in normalising the results of the Helicobacter pylori [13C]urea breath test for CO2 production rate in children? Isotopes Environ Health Stud. 2004;40:89–98.PubMedCrossRef
53.
go back to reference Winchell HS, Stahelin H, Kusubov N, et al. Kinetics of CO2-HCO3 minus in normal adult males. J Nucl Med. 1970;11:711–715.PubMed Winchell HS, Stahelin H, Kusubov N, et al. Kinetics of CO2-HCO3 minus in normal adult males. J Nucl Med. 1970;11:711–715.PubMed
54.
go back to reference Slater C, Preston T, Weaver LT. Comparison of accuracy and precision of heart rate calibration methods to estimate total carbon dioxide production during 13C-breath tests. Eur J Clin Nutr. 2006;60:69–76.PubMedCrossRef Slater C, Preston T, Weaver LT. Comparison of accuracy and precision of heart rate calibration methods to estimate total carbon dioxide production during 13C-breath tests. Eur J Clin Nutr. 2006;60:69–76.PubMedCrossRef
55.
go back to reference Amarri S, Harding M, Coward WA, Evans TJ, Weaver LT. 13C mixed triglyceride breath test and pancreatic enzyme supplementation in cystic fibrosis. Arch Dis Child. 1997;76:349–351.PubMedCrossRef Amarri S, Harding M, Coward WA, Evans TJ, Weaver LT. 13C mixed triglyceride breath test and pancreatic enzyme supplementation in cystic fibrosis. Arch Dis Child. 1997;76:349–351.PubMedCrossRef
56.
go back to reference Schneider A, Caspary WF, Saich R, et al. 13C-methacetin breath test shortened: 2-point-measurements after 15 minutes reliably indicate the presence of liver cirrhosis. J Clin Gastroenterol. 2007;41:33–37.PubMedCrossRef Schneider A, Caspary WF, Saich R, et al. 13C-methacetin breath test shortened: 2-point-measurements after 15 minutes reliably indicate the presence of liver cirrhosis. J Clin Gastroenterol. 2007;41:33–37.PubMedCrossRef
57.
go back to reference Forestier J, Dumortier J, Guillaud O, et al. Noninvasive diagnosis and prognosis of liver cirrhosis: a comparison of biological scores, elastometry, and metabolic liver function tests. Eur J Gastroenterol Hepatol. 2010;22:532–540.PubMedCrossRef Forestier J, Dumortier J, Guillaud O, et al. Noninvasive diagnosis and prognosis of liver cirrhosis: a comparison of biological scores, elastometry, and metabolic liver function tests. Eur J Gastroenterol Hepatol. 2010;22:532–540.PubMedCrossRef
58.
go back to reference Ecochard M, Boillot O, Guillaud O, et al. Could metabolic liver function tests predict mortality on waiting list for liver transplantation? A study on 560 patients. Clin Transplant. 2011;25:755–765.PubMedCrossRef Ecochard M, Boillot O, Guillaud O, et al. Could metabolic liver function tests predict mortality on waiting list for liver transplantation? A study on 560 patients. Clin Transplant. 2011;25:755–765.PubMedCrossRef
59.
go back to reference Razlan H, Marzuki NM, Tai ML, Shamsul AS, Ong TZ, Mahadeva S. Diagnostic value of the C methacetin breath test in various stages of chronic liver disease. Gastroenterol Res Pract. 2011;2011:235796.PubMed Razlan H, Marzuki NM, Tai ML, Shamsul AS, Ong TZ, Mahadeva S. Diagnostic value of the C methacetin breath test in various stages of chronic liver disease. Gastroenterol Res Pract. 2011;2011:235796.PubMed
60.
go back to reference Morelli A, Narducci F, Pelli MA, Farroni F, Vedovelli A. The relationship between aminopyrine breath test and severity of liver disease in cirrhosis. Am J Gastroenterol. 1981;76:110–113.PubMed Morelli A, Narducci F, Pelli MA, Farroni F, Vedovelli A. The relationship between aminopyrine breath test and severity of liver disease in cirrhosis. Am J Gastroenterol. 1981;76:110–113.PubMed
61.
go back to reference Afolabi P, Wright M, Carnegie C, et al. Assessment of hepatic function using [13C]-aminopyrine in patients with liver cirrhosis. Proceeding of the Nutrition Society. 2009;68:E129.CrossRef Afolabi P, Wright M, Carnegie C, et al. Assessment of hepatic function using [13C]-aminopyrine in patients with liver cirrhosis. Proceeding of the Nutrition Society. 2009;68:E129.CrossRef
62.
go back to reference Merkel C, Morabito A, Sacerdoti D, Bolognesi M, Angeli P, Gatta A. Updating prognosis of cirrhosis by Cox’s regression model using Child–Pugh score and aminopyrine breath test as time-dependent covariates. Ital J Gastroenterol Hepatol. 1998;30:276–282.PubMed Merkel C, Morabito A, Sacerdoti D, Bolognesi M, Angeli P, Gatta A. Updating prognosis of cirrhosis by Cox’s regression model using Child–Pugh score and aminopyrine breath test as time-dependent covariates. Ital J Gastroenterol Hepatol. 1998;30:276–282.PubMed
63.
go back to reference Degre D, Bourgeois N, Boon N, et al. Aminopyrine breath test compared to the MELD and Child–Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation. Transpl Int. 2004;17:31–38.PubMedCrossRef Degre D, Bourgeois N, Boon N, et al. Aminopyrine breath test compared to the MELD and Child–Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation. Transpl Int. 2004;17:31–38.PubMedCrossRef
64.
go back to reference Merkel C, Bolognesi M, Bellon S. Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis. Gut. 1992;33:836–842.PubMedCrossRef Merkel C, Bolognesi M, Bellon S. Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis. Gut. 1992;33:836–842.PubMedCrossRef
65.
Metadata
Title
Clinical Utility of 13C-Liver-Function Breath Tests for Assessment of Hepatic Function
Authors
P. Afolabi
M. Wright
S. A. Wootton
A. A. Jackson
Publication date
01-01-2013
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2013
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2340-z

Other articles of this Issue 1/2013

Digestive Diseases and Sciences 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.